Benefits and risks of estrogen replacement therapy

Area of Science:

• Reproductive Endocrinology
• Cardiovascular Health
• Gerontology

Background:

• Postmenopausal hormone therapy, including estrogen replacement therapy (ERT), is widely used.
• Estrogen therapy has demonstrated benefits in reducing cardiovascular disease (CVD) and osteoporosis risk.
• Potential risks and benefits require careful consideration for individual patient profiles.

Purpose of the Study:

• To review the established benefits of ERT in postmenopausal women.
• To examine the risks associated with ERT, including cancer and other adverse effects.
• To evaluate the impact of adding progestin (hormone replacement therapy) on ERT's efficacy and safety profile.

Main Methods:

• Review of epidemiological data and clinical studies on estrogen and hormone replacement therapy.
• Analysis of risk-benefit profiles concerning cardiovascular disease, osteoporosis, stroke, Alzheimer's disease, and cancer.
• Comparison of estrogen-only therapy versus combined hormone replacement therapy.

Main Results:

• ERT is associated with reduced risk of cardiovascular disease, stroke, and osteoporosis.
• Estrogen use may lower Alzheimer's disease risk and improve quality of life.
• Combined hormone therapy with progestin may eliminate endometrial cancer risk, with recent data suggesting no loss of CVD or bone protection.

Conclusions:

• The benefits of ERT and hormone replacement therapy, including reduced mortality and morbidity, are substantial and cost-effective.
• Risks, such as potential duration-related breast cancer, must be weighed against significant lifetime health risks.
• Informed patient-physician communication is crucial for navigating the risks and benefits of menopausal hormone therapy.